Attending Digital Health Festival? Click here.
Trusted by 4,500+ health leaders
Rua Bioscience is a New Zealand-based medicinal-cannabis biotech company grounded in Māori kaupapa and committed to global impact. Operated from Te Tairāwhiti, Masterton and Ruatōrea, Rua is engaged across genetics development, GMP manufacturing, and international distribution of cannabinoid-derived medicines.
Rua Bioscience was founded with a vision: to create cannabis-derived medicines that change people’s lives from Te Tairāwhiti, Aotearoa.
As one of the few Māori-born biotech firms and the only New Zealand-based medicinal-cannabis company with an explicit social-impact focus, Rua embraces values of integrity (Ponotanga), innovation (Mauitanga), health prioritisation (Oranga), and collaborative success (Whakawhanaungatanga).
Cultivation and genetic-discovery of unique cannabis varieties
GMP-certified manufacturing of cannabinoid medicines
Export distribution into key markets including Australia, UK, Germany and Czechia
Genetics & cultivation: Proprietary cannabis varieties developed in New Zealand soil and licensed for global markets.
Manufacturing & formulation: GMP-certified facility producing cannabinoid medicines (oils, dried flower, vaporisers) for prescription or specialist channels.
International distribution & export readiness: Partnering with distributors for UK, EU and Australian markets; regulatory and supply-chain support for global reach.
B2B partnership & supply opportunities: Works with prescriber networks, clinics, wellness brands, pharma, and export facilitators to supply cannabinoid-based therapeutics and devices.
Rua Bioscience is a strategic partner for:
Pharmaceutical or biotech firms seeking a cannabis-based product line, access to proprietary genetics or a manufacturing partner.
Distribution companies & importers focusing on medicinal cannabis markets in Australia, UK, Europe or Asia with need for GMP supply and unique product source.
Clinics, hospitals or prescriber networks requiring compliant cannabinoid medicines, clinical supply chains, and partner-led access support.
Wellness or health-consumer brands looking to integrate cannabinoid-derived products into premium healthy-ageing, pain-management or sleep-program portfolios (via correct regulatory channels).
Research and academic institutions seeking partnerships in cannabis genetics, agritech or pharmacology research aligned with Rua’s cultivation and R&D capacity.
Medicinal-cannabis genetics and cultivation strategy
Building pressure: what’s straining Australia’s hospitals and how to build resilience